Therapeutic breakthrough Year in review

Year in review
Chairs: H. Pinnock (Edinburgh (Edinburgh), United Kingdom), I. Vogiatzis (Newcastle upon tyne (Tyne and Wear), United Kingdom)
Aims: to highlight the key developments that are likely to influence care and improve outcomes for adults and children with respiratory diseases.

Triple therapy versus dual bronchodilation and long-acting ß-agonists/inhaled corticosteroids in COPD: accumulating evidence from network meta-analyses M. Cazzola (Roma (RM), Italy)
Azithromycin for early pseudomonas infection in cystic fibrosis: the OPTIMIZE randomised trial K. Grimwood (Gold Coast (QLD), Australia)
Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial E. Gimeno-Santos (Barcelona, Spain)
Extracorporeal assistance as bridge and as support during transplantation P. Corris (Newcastle-upon-Tyne, United Kingdom)